Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
282.40    -3.40 (-1.19%)
Bid:
281.60
Ask:
282.20
Spread: 0.60 (0.213%)
Market Cap: £711.61m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

30 Apr 2026 16:06

RNS Number : 6598C
Genuit Group PLC
30 April 2026
 

Genuit Group plc (the "Company")

The Company announces that on 24 April 2026, Joe Vorih, Chief Executive Officer and Person Discharging Managerial Responsibilities and Martin Gisbourne, Chief Strategy and Sustainability Officer and Persons Discharging Managerial Responsibilities, exercised nil-cost options over 26,034 and 5,055 ordinary shares respectively, in accordance with the Long-Term Incentive Plan awards granted on 21 April 2023, which vested on 21 April 2026. Both Mr. Vorih and Mr. Gisbourne sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Joe Vorih

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of ordinary shares for no consideration pursuant  to the exercise of nil-cost options under the Long-Term Incentive Plan ("LTIP") award granted on 21 April 2023.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

13,860 - Number of ordinary shares acquired after reduction for appropriate tax and national insurance

liabilities.

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

e)

 

Date of the transaction

 

 

24 April 2026

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Gisbourne

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Strategy and Sustainability Officer and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of ordinary shares for no consideration pursuant  to the exercise of nil-cost options under the LTIP award granted on 21 April 2023.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

2,581 - Number of ordinary shares acquired after reduction for appropriate tax and national insurance

liabilities.

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

e)

 

Date of the transaction

 

 

24 April 2026

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

Enquiries:

Colette Thompson, Deputy Company Secretary

 

+44 (0) 1138 315 315

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBKPBKDBQN
Date   Source Headline
23rd Dec 20259:06 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding
9th Dec 202510:44 amRNSHolding(s) in Company
3rd Dec 20255:11 pmRNSHolding(s) in Company
3rd Dec 20254:56 pmRNSDirector/PDMR Shareholding
3rd Dec 20254:39 pmRNSDirector/PDMR Shareholding
3rd Dec 202510:00 amRNSHolding(s) in Company
2nd Dec 20255:09 pmRNSHolding(s) in Company
27th Nov 20254:49 pmRNSHolding(s) in Company
18th Nov 20254:28 pmRNSBlock Listing Application
18th Nov 20253:31 pmRNSDirector/PDMR Shareholding
17th Nov 20257:00 amRNSTrading Update
10th Nov 202511:40 amRNSHolding(s) in Company
7th Nov 20252:26 pmRNSHolding(s) in Company
3rd Nov 202510:00 amRNSBlock listing Interim Review
15th Oct 20251:30 pmRNSDirector/PDMR Shareholding
30th Sep 20253:51 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAcquisition of Davidson Holdings
18th Sep 20253:26 pmRNSDirectorate Change
1st Sep 20257:00 amRNSAcquisition of Monodraught
19th Aug 20256:11 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf-year Report
26th Jun 20254:21 pmRNSDirector/PDMR Shareholding
20th Jun 20254:22 pmRNSDirectorate Change
19th May 20251:37 pmRNSResult of AGM
19th May 20257:00 amRNSTrading Statement
1st May 202512:26 pmRNSBlock listing Interim Review
15th Apr 20259:49 amRNSNotice of AGM
11th Mar 20257:00 amRNSFinal Results
21st Feb 20254:25 pmRNSHolding(s) in Company
14th Feb 20255:00 pmRNSHolding(s) in Company
28th Jan 202510:05 amRNSHolding(s) in Company
21st Jan 20251:53 pmRNSHolding(s) in Company
2nd Jan 202510:01 amRNSHolding(s) in Company
23rd Dec 20242:58 pmRNSHolding(s) in Company
19th Dec 20243:20 pmRNSDirector/PDMR Shareholding
17th Dec 202412:32 pmRNSHolding(s) in Company
12th Dec 20245:25 pmRNSHolding(s) in Company
25th Nov 20241:01 pmRNSDirector/PDMR Shareholding
19th Nov 20245:55 pmRNSHolding(s) in Company
19th Nov 20247:00 amRNSTrading Update
15th Nov 20243:10 pmRNSHolding(s) in Company
1st Nov 20241:37 pmRNSBlock listing Interim Review
31st Oct 20241:14 pmRNSHolding(s) in Company
11th Oct 202412:23 pmRNSHolding(s) in Company
7th Oct 20244:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.